| Page 1601 | Kisaco Research
 

Claire Smith

Biotech VC
Anterra Capital

Claire is an Associate at Anterra Capital. Prior to joining Anterra, she was the Chief of Staff at Crestovo, a biotech start-up developing microbiome-based therapies for infectious diseases. Before that, she worked as a consultant at ClearView Healthcare Partners, where she advised pharmaceutical and biotech clients on a variety of growth strategy topics. She graduated from the Massachusetts Institute of Technology with Bachelor of Science degrees in biological engineering and management science.

Read full bio

Claire Smith

Biotech VC
Anterra Capital

Claire Smith

Biotech VC
Anterra Capital

Claire is an Associate at Anterra Capital. Prior to joining Anterra, she was the Chief of Staff at Crestovo, a biotech start-up developing microbiome-based therapies for infectious diseases. Before that, she worked as a consultant at ClearView Healthcare Partners, where she advised pharmaceutical and biotech clients on a variety of growth strategy topics. She graduated from the Massachusetts Institute of Technology with Bachelor of Science degrees in biological engineering and management science.

Kisaco Leadership Chart on Enterprise ML Lifecycle Solutions 2020-21

30.07.2020

  • Motivation

    For enterprises looking to build and deploy ML applications there are multiple hurdles to overcome: team skills, team collaboration, maturity of deployment process, industrialization of ML application development lifecycle, monitoring production and managing change and updates. While many of these steps and concepts are familiar to software engineers they are novel to data science teams and line of business (LOB) teams, and the parallel between ML application development and software application development only goes so far and the former has quite distinct requirements.

Request a sample

Please complete the form below to receive a sample of this report.

Covid-19 and the Digitisation of Animal Health in Latin America